Trials / Completed
CompletedNCT00683982
Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus
Nitazoxanide vs Probiotics in the Treatment of Acute Rotavirus Diarrhea in Children: A Randomized Single Blind Controlled Trial in Bolivian Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Centro Pediatrico Albina de Patino · Academic / Other
- Sex
- All
- Age
- 28 Days – 24 Months
- Healthy volunteers
- Not accepted
Summary
Nitazoxanide has proved an cytoprotective effect against rotavirus infection. How it could be clinically important in time of hospitalization and reduction of duration of diarrhea secondary to rotavirus?
Detailed description
Nitazoxanide has demonstrated a cytoprotective effect against rotavirus, reducing duration time of diarrhea in comparison to placebo in previous studies. In the current study, based in those results, we design a randomized single-blind controlled trial, in order to asses the effectiveness of nitazoxanide and probiotics in comparison with a control group
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitazoxanide | Nitazoxanide 15mg/Kg/day twice day for 3 days |
| DRUG | Probiotic mix preparation | Probiotic preparation 1 gram twice a day for 5 days |
| OTHER | Oral hydration solutions | Oral hydration solutions as needed |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2008-05-26
- Last updated
- 2008-05-26
Locations
1 site across 1 country: Bolivia
Source: ClinicalTrials.gov record NCT00683982. Inclusion in this directory is not an endorsement.